EU Regulator ‘convinced’ AstraZeneca Benefit Outweighs Risk

Pharmacist Rajan Shah prepares a syringe of the AstraZeneca vaccine at St John's Church, in Ealing, London, Tuesday, March 16, 2021. In recent days, countries including Denmark, Ireland and Thailand have temporarily suspended their use of AstraZeneca's coronavirus vaccine after reports that some people who got a dose developed blood clots, even though there's no evidence that the shot was responsible. The European Medicines Agency and the World Health Organization say the data available do not suggest the vaccine caused the clots.​ Britain and several other countries have stuck with the vaccine. (AP Photo/Kirsty Wigglesworth)

(AP) — The European Union’s drug regulator is insisting that there is “no indication” the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to save lives or suspend its use over reports of clotting in some recipients.

The European Medicines Agency urged governments Tuesday not to halt use of the vaccine at a time when the pandemic is still taking thousands of lives each day. And already there are concerns that even brief suspensions could have disastrous effects on confidence in inoculation campaigns the world over. Many of those are already struggling to overcome logistical hurdles and widespread hesitancy about experimental vaccines.


Homeland Security Chief Defends US Handling Of Border Surge

Previous article

Hospitalizations In Texas From COVID-19 Continue To Drop

Next article

You may also like

More in WORLD